241 related articles for article (PubMed ID: 8202986)
1. Pretreatment of transient focal cerebral ischemia in rats with the calcium antagonist AT877.
Ohtaki M; Tranmer B
Stroke; 1994 Jun; 25(6):1234-9; discussion 1240. PubMed ID: 8202986
[TBL] [Abstract][Full Text] [Related]
2. Hypertonic saline worsens infarct volume after transient focal ischemia in rats.
Bhardwaj A; Harukuni I; Murphy SJ; Alkayed NJ; Crain BJ; Koehler RC; Hurn PD; Traystman RJ
Stroke; 2000 Jul; 31(7):1694-701. PubMed ID: 10884475
[TBL] [Abstract][Full Text] [Related]
3. The effect of ritanserin, a 5-HT2 receptor antagonist, on ischemic cerebral blood flow and infarct volume in rat middle cerebral artery occlusion.
Takagi K; Ginsberg MD; Globus MY; Busto R; Dietrich WD
Stroke; 1994 Feb; 25(2):481-5; discussion 485-6. PubMed ID: 8303760
[TBL] [Abstract][Full Text] [Related]
4. Preischemic but not postischemic zinc protoporphyrin treatment reduces infarct size and edema accumulation after temporary focal cerebral ischemia in rats.
Kadoya C; Domino EF; Yang GY; Stern JD; Betz AL
Stroke; 1995 Jun; 26(6):1035-8. PubMed ID: 7762020
[TBL] [Abstract][Full Text] [Related]
5. Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri.
Schäbitz WR; Hoffmann TT; Heiland S; Kollmar R; Bardutzky J; Sommer C; Schwab S
Stroke; 2001 May; 32(5):1226-33. PubMed ID: 11340238
[TBL] [Abstract][Full Text] [Related]
6. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial.
Shibuya M; Suzuki Y; Sugita K; Saito I; Sasaki T; Takakura K; Nagata I; Kikuchi H; Takemae T; Hidaka H
J Neurosurg; 1992 Apr; 76(4):571-7. PubMed ID: 1545249
[TBL] [Abstract][Full Text] [Related]
7. Infarct tolerance against temporary focal ischemia following spreading depression in rat brain.
Yanamoto H; Hashimoto N; Nagata I; Kikuchi H
Brain Res; 1998 Feb; 784(1-2):239-49. PubMed ID: 9518633
[TBL] [Abstract][Full Text] [Related]
8. Prereperfusion saline infusion into ischemic territory reduces inflammatory injury after transient middle cerebral artery occlusion in rats.
Ding Y; Li J; Rafols JA; Phillis JW; Diaz FG
Stroke; 2002 Oct; 33(10):2492-8. PubMed ID: 12364743
[TBL] [Abstract][Full Text] [Related]
9. Postischemic brain injury is affected stereospecifically by pentazocine in rats.
Takahashi H; Traystman RJ; Hashimoto K; London ED; Kirsch JR
Anesth Analg; 1997 Aug; 85(2):353-7. PubMed ID: 9249113
[TBL] [Abstract][Full Text] [Related]
10. The effect of a new calcium antagonist, TA3090 (clentiazem), on experimental transient focal cerebral ischemia in cats.
Sakaki T; Tsujimoto S; Sasaoka Y; Tsunoda S; Shintomi K
Stroke; 1993 Jun; 24(6):872-8; discussion 879. PubMed ID: 8506559
[TBL] [Abstract][Full Text] [Related]
11. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
[TBL] [Abstract][Full Text] [Related]
12. Treatment of focal cerebral ischemia with synthetic oligopeptide corresponding to lectin domain of selectin.
Morikawa E; Zhang SM; Seko Y; Toyoda T; Kirino T
Stroke; 1996 May; 27(5):951-5; discussion 956. PubMed ID: 8623118
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection in transient focal cerebral ischemia by combination drug therapy and mild hypothermia: comparison with customary therapeutic regimen.
Zausinger S; Westermaier T; Plesnila N; Steiger HJ; Schmid-Elsaesser R
Stroke; 2003 Jun; 34(6):1526-32. PubMed ID: 12730554
[TBL] [Abstract][Full Text] [Related]
14. The competitive NMDA antagonist MDL-100,453 reduces infarct size after experimental stroke.
Hasegawa Y; Fisher M; Baron BM; Metcalf G
Stroke; 1994 Jun; 25(6):1241-4; discussion 1245-6. PubMed ID: 8202987
[TBL] [Abstract][Full Text] [Related]
15. Dose escalation trial of a novel calcium antagonist, AT877, in patients with aneurysmal subarachnoid haemorrhage.
Shibuya M; Suzuki Y; Sugita K; Saito I; Sasaki T; Takakura K; Okamoto S; Kikuchi H; Takemae T; Hidaka H
Acta Neurochir (Wien); 1990; 107(1-2):11-5. PubMed ID: 2096602
[TBL] [Abstract][Full Text] [Related]
16. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
Tatlisumak T; Takano K; Meiler MR; Fisher M
Stroke; 1998 Jan; 29(1):190-5. PubMed ID: 9445350
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective FK506 does not alter in vivo nitric oxide production during ischemia and early reperfusion in rats.
Toung TJ; Bhardwaj A; Dawson VL; Dawson TM; Traystman RJ; Hurn PD
Stroke; 1999 Jun; 30(6):1279-85. PubMed ID: 10356112
[TBL] [Abstract][Full Text] [Related]
18. Focal cerebral ischemia in chronic hypertension: no protection by (R)-phenylisopropyladenosine.
Roussel S; Pinard E; Seylaz J
Brain Res; 1991 Apr; 545(1-2):171-4. PubMed ID: 1860043
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats.
Goyagi T; Toung TJ; Kirsch JR; Traystman RJ; Koehler RC; Hurn PD; Bhardwaj A
Stroke; 2003 Jun; 34(6):1533-8. PubMed ID: 12738895
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic time window of hypothermia is broader than cerebral artery flushing in carotid saline infusion after transient focal ischemic stroke in rats.
Ji Y; Hu Y; Wu Y; Ji Z; Song W; Wang S; Pan S
Neurol Res; 2012 Sep; 34(7):657-63. PubMed ID: 22709718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
